Leaving BNY Website

 

You are leaving the BNY Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2024 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
 

To learn more about DRs, please contact DRBrokerSolutions@bnymellon.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.24%, DAX30 +0.35%, CAC40 +0.33%

Jun 06 ,2024

  • Synopsis

    • European equity markets are set to open higher amidst Asian equities mostly higher Thursday. Nikkei rebounding amid strong gains in semis. Chip stocks also driving Taiwan's index higher with TSMC launching buyback. Hang Seng leading China market gains though property stocks back under pressure. S&P 500 futures steady afterhours. Sweden closed for National Day.

    • On today's agenda, Netherland is the first country to vote in European parliamentary elections (bulk of the countries vote on Sun (9th)). BDEW Congress takes place with speakers including minister of economics Habeck at 13:25CET. Entrepreneurs' Day NRW; Guest speaker is minister of finance Lindner. Norway's PM Støre and defense minister Gram in Normandy, France, and are among the participants in a commemoration of 80 years since D-Day. Russia May new car registrations.

    • In central banks, focus on ECB interest rate decision at 14:15CET, press conf. 14:45. Expectations are for a 25bps cut in the benchmark interest rate. Release will be accompanied by the latest staff economic projections. Other central bank events include Bank of Finland's Deputy Governor Nykänen speech at 8:00CET at RiskLab/BoF/ESRB Conf on AI and Systemic Risk Analytics and Czech Central Bank meeting on Financial Stability.

    • Macro releases due today include: Germany Apr factory orders and May construction PMI, Switzerland May unemployment rate, Spain Apr industrial production, Italy Apr retail sales, UK May construction PMI, Greece Q1 unemployment rate, Eurozone Apr retail sales, Ireland May unemployment rate.

    • In Corporate news, Norcod (NCOD.NO) and (Addex Therapeutics (ADXN.SW) reported Q1 earnings this morning. In Greece, Piraeus Financial (TPEIR.GA) provided its updated 2024 guidance. In France, Remy Cointreau (RCO.FP) issued its FY earnings and reiterated both its financial and extra-financial targets for 2029-2030. In M&A, Atos (ATO.FP) extended the deadline for selection of preferred financial restructuring proposal to the beginning of the week of 10-Jun-24.

  • Politics/Macro/World News

    • Sunak's Cap on Migration Would Complicate BOE's Inflation Fight - Bloomberg

    • ECB Is Set to Begin Cuts But Path Beyond Gets Murkier - Bloomberg

    • Reform UK just two points behind Tories in new poll - The Telegraph

    • 'There's life in the UK economy' as growth forecast upgraded - The Times

  • Top company news

    • Earnings/updates

      • ADXN.SW (Addex Therapeutics) -- reports Q1 EPS continuing ops (CHF0.01) vs year-ago (CHF0.01)

      • TPEIR.GA (Piraeus Financial Holdings) -- Piraeus Financial provides updated 2024 guidance

      • NCOD.NO (Norcod) -- reports Q1 net income (NOK55.0M) vs year-ago (NOK42.8M)

      • FBK.IM (FinecoBank) -- reports May net sales €945.6M vs year-ago €867.5M

    • M&A

      • ATO.FP (ATOS SE) -- Atos extends deadline for selection of preferred financial restructuring proposal to the beginning of the week of 10-Jun-24

      • DG.FP (VINCI SA) -- acquires two roadworks and materials production companies in the US and Canada; terms undisclosed

      • NEM.GR (Nemetschek) -- to acquire GoCanvas Holdings; terms undisclosed

      • WG.LN (John Wood Group) -- board engages with Sidara; PUSU deadline extended to 3-Jul-24

      • Loscam could look to split and sell operations separately - The Australian

    • Healthcare

      • EXEL (Exelixis) -- FDA grants orphan drug designation to cabozantinib for treatment of pancreatic neuroendocrine tumors

      • ARGX.BB (argenx) -- FDA grants orphan drug designation to empasiprubart for multifocal motor neuropathy

    • Other

      • VOW.GR (Volkswagen) -- could outsource hundreds of jobs or more to outside companies in Germany - Handelsblatt

      • ANTO.LN (Antofagasta) -- announces completion of process to transfer Centinela's water supply infrastructure

      • TE.FP (Technip Energies) -- and Turner Industries Awarded Contract by ExxonMobil for Louisiana Carbon Capture and Sequestration Project

      • VPK.NA (Royal Vopak) -- awards FEED contract for CO2next project to Sener

  • Key rating changes

    • Upgrades

      • GET.FP (Getlink) -- to overweight from equal weight at Barclays

    • Downgrades

      • EKTA.B.SS (Elekta) -- to hold from buy at SEB

    • Initiations

      • JET2.LN (Jet2) -- outperform at Davy

      • CVC.NA (CVC Capital Partners) --

        • buy at Goldman Sachs

        • buy at Deutsche Bank

        • overweight at Morgan Stanley

        • neutral at UBS

        • neutral at JPMorgan

      • buy at ING

      • neutral at Oddo

    • VSVS.LN (Vesuvius) -- buy at HSBC

    • PDX.SS (Paradox Interactive) -- underweight at Barclays

  • Other Actions

    • BHP.LN (BHP Group) -- reinstated neutral at Goldman Sachs

    • DCC.LN (DCC) -- reinstated overweight at JPMorgan

Data

  • Nikkei +0.70% to 38757.87

  • Hang Seng +0.07% to 18436.94

  • Shanghai Composite (0.18%) to 3059.75

  • S&P futures +0.3 vs prior close of 5366.0

  • €-$ +0.0016 or +0.15% to 1.0886

  • $-¥ (0.19) or (0.12%) to 155.88

  • €-¥ (0.03) or (0.02%) to 169.67

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE